Generic Name
Carbinoxamine
Brand Names
Carbzah, Karbinal, RyVent
FDA approval date: May 27, 2011
Classification: Histamine-1 Receptor Antagonist
Form: Tablet, Suspension, Solution
What is Carbzah (Carbinoxamine)?
Carbinoxamine maleate is effective for the symptomatic treatment of: Seasonal and perennial allergic rhinitis. Vasomotor rhinitis. Allergic conjunctivitis due to inhalant allergens and foods. Mild, uncomplicated allergic skin manifestations of urticaria and angioedema. Dermatographism. As therapy for anaphylactic reactions adjunctive to epinephrine and other standard measures after the acute manifestations have been controlled. Amelioration of the severity of allergic reactions to blood or plasma.
Approved To Treat
Save this treatment for later
Not sure about your diagnosis?
Related Clinical Trials
There is no clinical trials being done for this treatment